Towards tricking a pathogen's protease into fighting infection: the 3D structure of a stable circularly permuted onconase variant cleavedby HIV-1 protease.
Onconase® is a highly cytotoxic amphibian homolog of Ribonuclease A. Here, we describe the construction of circularly permuted Onconase® variants by connecting the N- and C-termini of this enzyme with amino acid residues that are recognized and cleaved by the human immunodeficiency virus protease. U...
Main Authors: | Mariona Callís, Soraya Serrano, Antoni Benito, Douglas V Laurents, Maria Vilanova, Marta Bruix, Marc Ribó |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3548804?pdf=render |
Similar Items
-
Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents
by: Jessica Castro, et al.
Published: (2021-01-01) -
Onconase: A ribonuclease with antitumor activity
by: Małgorzata Zwolińska, et al.
Published: (2010-02-01) -
Non-apoptotic roles of apoptotic proteases: new tricks for an old dog
by: Tin Tin Su
Published: (2020-08-01) -
New Yoyo Tricks with AES-based Permutations
by: Dhiman Saha, et al.
Published: (2018-12-01) -
The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma
by: Luciano Mutti, et al.
Published: (2011-12-01)